Transforming growth factor-β promotes basement membrane fibrosis, alters perivascular cerebrospinal fluid distribution, and worsens neurological recovery in the aged brain after stroke.
Aged
Animals
Basement Membrane
/ pathology
Benzamides
/ pharmacology
Biomarkers
/ blood
Brain
/ metabolism
Cerebrospinal Fluid
/ metabolism
Female
Fibronectins
/ metabolism
Fibrosis
Humans
Male
Mice, Inbred C57BL
Pyrazoles
/ pharmacology
Receptors, Transforming Growth Factor beta
/ antagonists & inhibitors
Recovery of Function
/ physiology
Stroke
/ physiopathology
Transforming Growth Factor beta
/ blood
Amyloid-β
Astrocyte
Basement membrane
Cerebrospinal fluid
Stroke
TGF-β
Journal
GeroScience
ISSN: 2509-2723
Titre abrégé: Geroscience
Pays: Switzerland
ID NLM: 101686284
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
04
09
2019
accepted:
04
10
2019
pubmed:
14
11
2019
medline:
22
5
2020
entrez:
14
11
2019
Statut:
ppublish
Résumé
Aging and stroke alter the composition of the basement membrane and reduce the perivascular distribution of cerebrospinal fluid and solutes, which may contribute to poor functional recovery in elderly patients. Following stroke, TGF-β induces astrocyte activation and subsequent glial scar development. This is dysregulated with aging and could lead to chronic, detrimental changes within the basement membrane. We hypothesized that TGF-β induces basement membrane fibrosis after stroke, leading to impaired perivascular CSF distribution and poor functional recovery in aged animals. We found that CSF entered the aged brain along perivascular tracts; this process was reduced by experimental stroke and was rescued by TGF-β receptor inhibition. Brain fibronectin levels increased with experimental stroke, which was reversed with inhibitor treatment. Exogenous TGF-β stimulation increased fibronectin expression, both in vivo and in primary cultured astrocytes. Oxygen-glucose deprivation of cultured astrocytes induced multiple changes in genes related to astrocyte activation and extracellular matrix production. Finally, in stroke patients, we found that serum TGF-β levels correlated with poorer functional outcomes, suggesting that serum levels may act as a biomarker for functional recovery. These results support a potential new treatment strategy to enhance recovery in elderly stroke patients.
Identifiants
pubmed: 31721012
doi: 10.1007/s11357-019-00118-7
pii: 10.1007/s11357-019-00118-7
pmc: PMC6885082
doi:
Substances chimiques
4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide
0
Benzamides
0
Biomarkers
0
Fibronectins
0
Pyrazoles
0
Receptors, Transforming Growth Factor beta
0
Transforming Growth Factor beta
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
543-559Subventions
Organisme : NINDS NIH HHS
ID : R01 NS094543
Pays : United States
Organisme : NIA NIH HHS
ID : RF1AG057576
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston
ID : 4TL1TR000369-10
Pays : International
Organisme : NINDS NIH HHS
ID : R01NS094543
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG057576
Pays : United States
Références
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):E3872-81
pubmed: 27317747
Am J Pathol. 2000 Jan;156(1):139-50
pubmed: 10623661
Acta Neuropathol. 2018 Jul;136(1):139-152
pubmed: 29754206
Stroke. 2011 Sep;42(9):2672-713
pubmed: 21778438
Acta Neuropathol. 2011 Apr;121(4):431-43
pubmed: 21259015
J Physiol. 2018 Feb 1;596(3):445-475
pubmed: 29023798
Acta Neuropathol Commun. 2018 Sep 24;6(1):100
pubmed: 30249297
J Neurosci. 2013 Nov 13;33(46):18190-9
pubmed: 24227727
Exp Neurobiol. 2019 Aug 31;28(4):458-473
pubmed: 31495075
PLoS Negl Trop Dis. 2012;6(6):e1696
pubmed: 22720109
Nature. 2017 Jan 26;541(7638):481-487
pubmed: 28099414
Restor Neurol Neurosci. 2015;33(4):493-507
pubmed: 26409408
J Alzheimers Dis. 2016 Oct 18;54(4):1629-1647
pubmed: 27636841
J Neuroimmunol. 2002 Jun;127(1-2):160-8
pubmed: 12044988
Acta Neuropathol. 2016 May;131(5):725-36
pubmed: 26975356
Am J Pathol. 1995 Jul;147(1):53-67
pubmed: 7604885
Glia. 2014 Aug;62(8):1227-40
pubmed: 24733756
J Cereb Blood Flow Metab. 2014 Oct;34(10):1637-45
pubmed: 25052558
Stroke. 1996 May;27(5):852-7
pubmed: 8623105
Geroscience. 2017 Feb;39(1):33-42
pubmed: 28299642
Int J Mol Sci. 2017 Apr 05;18(4):
pubmed: 28379162
Sci Transl Med. 2012 Aug 15;4(147):147ra111
pubmed: 22896675
J Neuroinflammation. 2010 Oct 11;7:62
pubmed: 20937129
J Neurosci. 2012 May 2;32(18):6391-410
pubmed: 22553043
Semin Immunopathol. 2009 Nov;31(4):497-511
pubmed: 19779720
Neurobiol Aging. 2018 Dec;72:1-13
pubmed: 30172921
J Neurosci. 2014 Dec 3;34(49):16180-93
pubmed: 25471560
J Cereb Blood Flow Metab. 2017 Oct;37(10):3300-3317
pubmed: 28753105
J Neurosci. 2017 Mar 15;37(11):2870-2877
pubmed: 28188218
J Clin Invest. 2017 Jan 3;127(1):280-292
pubmed: 27893460
Molecules. 2017 Feb 24;22(3):
pubmed: 28245546
J Cereb Blood Flow Metab. 2002 May;22(5):526-33
pubmed: 11973425
Geroscience. 2017 Dec;39(5-6):601-614
pubmed: 29243191
Science. 2013 Oct 18;342(6156):373-7
pubmed: 24136970
Ann N Y Acad Sci. 2002 Nov;977:87-95
pubmed: 12480736
Methods Mol Biol. 2014;1135:103-10
pubmed: 24510858
Acta Neuropathol. 2019 Jan;137(1):151-165
pubmed: 30306266
J Neurosci Methods. 2006 Jan 15;150(1):128-37
pubmed: 16105687
Nature. 1997 Oct 9;389(6651):603-6
pubmed: 9335500
Oncotarget. 2017 Jan 10;8(2):3553-3567
pubmed: 27682880
Lancet Neurol. 2019 May;18(5):459-480
pubmed: 30879893
Neurobiol Aging. 2002 May-Jun;23(3):349-62
pubmed: 11959396
Acta Biochim Biophys Sin (Shanghai). 2018 Jan 1;50(1):12-36
pubmed: 29293886
PLoS One. 2012;7(7):e41636
pubmed: 22848551
J Med Chem. 2006 Apr 6;49(7):2210-21
pubmed: 16570917
J Cereb Blood Flow Metab. 2015 Mar;35(3):371-81
pubmed: 25492117
Brain Behav Immun. 2011 Nov;25(8):1689-700
pubmed: 21756996
Ann Neurol. 2014 Dec;76(6):845-61
pubmed: 25204284